Latest Drug-induced lupus erythematosus Stories
To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/first-new-lupus-treatment-in-almost-50-years MARKHAM, ON, July 12, 2011 /PRNewswire/ - Health Canada's recent approval of BENLYSTA(TM) marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known cause or cure.
The New York City-based S.L.E. Lupus Foundation and its West Coast division Lupus LA welcome the U.S.
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today.
WASHINGTON, July 9 /PRNewswire-USNewswire/ -- In response to a recent increase in media interest in lupus, the Lupus Foundation of America (LFA) is providing a fact sheet about the disease.
Some 93 percent of patients with lupus erythematosus suffer anxiety and depression affecting physical and emotional quality of life, Italian researchers say. In the study, 92.8 percent of 56 patients who were diagnosed with systemic lupus erythematosus had an element of confirmed neuropsychiatric involvement -- including anxiety, depression, mild cognitive deficits and major neuropsychiatric involvement. Several other conditions that may occur alongside systemic lupus erythematosus were also...
Study found use of oral contraceptives was associated with an increased risk of SLE, particularly among women who had recently started taking them.